April 2020 | Lisa Clemans-Cope, Emma Winiski, Marni Epstein | Patient Access to Facility-Based Opioid Use Disorder Treatment in New Jersey in 2019
Expanding access to effective treatment for opioid use disorder (OUD) is essential to staunching the opioid epidemic. This brief presents findings from the second round of a telephone survey that assessed patient access to treatment services for OUD at facilities that offered OUD pharmacotherapy (buprenorphine, methadone, or naltrexone) across New Jersey in 2019. We also monitor changes in access to treatment from 2018 to 2019. We present data on specific treatment service availability, wait times, and Medicaid coverage of treatment, including region- and county-specific data to assess the supply and demand of various treatment options throughout the state.